Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics.
The ADHD Drugs in Development market research report provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for ADHD, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for ADHD and features dormant and discontinued projects.
ADHD Pipeline Drugs Market Targets
Some of the targets of the ADHD pipeline drugs market are Sodium Dependent Noradrenaline Transporter, Sodium Dependent Dopamine Transporter, D3 Dopamine Receptor, 5-Hydroxytryptamine Receptor 2A, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 1A, D2 Dopamine Receptor, D4 Dopamine Receptor, 5-Hydroxytryptamine Receptor, 5-Hydroxytryptamine Receptor 1B.
ADHD pipeline drugs market, by targets
For more target insights, download a free report sample
Mechanisms of Action of ADHD Pipeline Drugs Market
Some of the mechanisms of action of the ADHD pipeline drugs market are Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Dopamine Transporter Inhibitor, D3 Dopamine Receptor Agonist, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 1A Agonist, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2A Antagonist, D2 Dopamine Receptor Agonist, D4 Dopamine Receptor Agonist, and 5-Hydroxytryptamine Receptor 1B Agonist.
ADHD pipeline drugs market, by mechanisms of action
For more mechanisms of action insights, download a free report sample
Routes of Administration in ADHD Pipeline Drugs Market
The routes of administration in the ADHD pipeline drugs market are oral, transdermal, nasal, and subcutaneous.
ADHD pipeline drugs market, by routes of administration
For more routes of administration insights, download a free report sample
Molecule Types in ADHD Pipeline Drugs Market
The molecule types in the ADHD pipeline drugs market are small molecule, biologic, and enzyme.
ADHD pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Key ADHD Pipeline Drugs Market Companies
Some of the key companies in the ADHD pipeline drugs market are 3Z ehf, NLS Pharmaceutics AG, Tris Pharma Inc, Supernus Pharmaceuticals Inc, Cingulate Therapeutics LLC, Ensysce Biosciences Inc, MD Healthcare Inc, 4P-Pharma SAS, ABVC BioPharma Inc, and AgoneX Biopharmaceuticals Inc.
ADHD pipeline drugs market, by key companies
To know more about key companies, download a free report sample
Market report overview
| Targets | Sodium Dependent Noradrenaline Transporter, Sodium Dependent Dopamine Transporter, D3 Dopamine Receptor, 5-Hydroxytryptamine Receptor 2A, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 1A, D2 Dopamine Receptor, D4 Dopamine Receptor, 5-Hydroxytryptamine Receptor, 5-Hydroxytryptamine Receptor 1B |
| Mechanisms of Action | Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Dopamine Transporter Inhibitor, D3 Dopamine Receptor Agonist, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 1A Agonist, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2A Antagonist, D2 Dopamine Receptor Agonist, D4 Dopamine Receptor Agonist, and 5-Hydroxytryptamine Receptor 1B Agonist |
| Routes of Administration | Oral, Transdermal, Nasal, and Subcutaneous |
| Molecule Types | Small Molecule, Biologic, and Enzyme |
| Key Companies | 3Z ehf, NLS Pharmaceutics AG, Tris Pharma Inc, Supernus Pharmaceuticals Inc, Cingulate Therapeutics LLC, Ensysce Biosciences Inc, MD Healthcare Inc, 4P-Pharma SAS, ABVC BioPharma Inc, and AgoneX Biopharmaceuticals Inc |
Scope
This report provides:
- A snapshot of the global therapeutic landscape of Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System).
- Reviews of pipeline therapeutics for Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on several stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which include product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key companies involved in Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) therapeutics and enlists all their major and minor projects.
- Evaluation of Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) targeted therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA), and molecule type.
- All the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to pipeline therapeutics for Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System).
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
4P-Pharma SAS
ABVC BioPharma Inc
AgoneX Biopharmaceuticals Inc
Altus Formulation Inc
Amarantus Bioscience Holdings Inc
Arbor Pharmaceuticals LLC
Attentive Therapeutics Inc
Avekshan LLC
BCWorld Pharm Co Ltd
Cennerv Pharma (S) Pte Ltd
Cingulate Therapeutics LLC
Collegium Pharmaceutical Inc
Commave Therapeutics SA
Curemark LLC
DD Therapeutics LLC
DURECT Corp
Eli Lilly and Co
EncepHeal Therapeutics Inc
Ensysce Biosciences Inc
Highland Therapeutics Inc
Hyloris Pharmaceuticals SA
INVENT Pharmaceuticals Inc
Kashiv BioSciences LLC
KemPharm Inc
Lennham Pharmaceuticals Inc
M et P Pharma AG
Marvel Biotechnology Inc
MD Healthcare Inc
Mind Medicine MindMed Inc
Mindset Pharma Inc
NeuroNascent Inc
NLS Pharmaceutics AG
Nobias Therapeutics Inc
NutriBand Inc
Oryzon Genomics SA
Otsuka Pharmaceutical Co Ltd
OWP Pharmaceuticals Inc
P2D Inc
PolyCore Therapeutics LLC
RespireRx Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Shenox Pharmaceuticals LLC
Shionogi & Co Ltd
SK Biopharmaceuticals Co Ltd
Supernus Pharmaceuticals Inc
Suven Life Sciences Ltd
Taho Pharmaceuticals Ltd
Tonix Pharmaceuticals Holding Corp
Tris Pharma Inc
Vallon Pharmaceuticals Inc
Yichang Renfu Pharmaceutical Co Ltd
Yuyu Pharma Inc
Table of Contents
Frequently asked questions
-
What are the targets of the ADHD pipeline drugs market?
Some of the targets of the ADHD pipeline drugs market are Sodium Dependent Noradrenaline Transporter, Sodium Dependent Dopamine Transporter, D3 Dopamine Receptor, 5-Hydroxytryptamine Receptor 2A, Sodium Dependent Serotonin Transporter, 5-Hydroxytryptamine Receptor 1A, D2 Dopamine Receptor, D4 Dopamine Receptor, 5-Hydroxytryptamine Receptor, 5-Hydroxytryptamine Receptor 1B.
-
What are the mechanisms of action of the ADHD pipeline drugs market?
Some of the mechanisms of action of the ADHD pipeline drugs market are Sodium Dependent Noradrenaline Transporter Inhibitor, Sodium Dependent Dopamine Transporter Inhibitor, D3 Dopamine Receptor Agonist, Sodium Dependent Serotonin Transporter Inhibitor, 5-Hydroxytryptamine Receptor 1A Agonist, 5-Hydroxytryptamine Receptor 2A Agonist, 5-Hydroxytryptamine Receptor 2A Antagonist, D2 Dopamine Receptor Agonist, D4 Dopamine Receptor Agonist, and 5-Hydroxytryptamine Receptor 1B Agonist.
-
What are the routes of administration in the ADHD pipeline drugs market?
The routes of administration in the ADHD pipeline drugs market are oral, transdermal, nasal, and subcutaneous.
-
What are the molecule types in the ADHD pipeline drugs market?
The molecule types in the ADHD pipeline drugs market are small molecule, biologic, and enzyme.
-
Which are the key companies in the ADHD pipeline drugs market?
Some of the key companies in the ADHD pipeline drugs market are 3Z ehf, NLS Pharmaceutics AG, Tris Pharma Inc, Supernus Pharmaceuticals Inc, Cingulate Therapeutics LLC, Ensysce Biosciences Inc, MD Healthcare Inc, 4P-Pharma SAS, ABVC BioPharma Inc, and AgoneX Biopharmaceuticals Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Central Nervous System reports